 |
||||
|
||||
|
||||
|
||||
Previous Article | Next Article
The Journal of Neuroscience, September 1, 2002, 22(17):7526-7535
Matrix Metalloproteinases Limit Functional Recovery after Spinal Cord Injury by Modulation of Early Vascular Events
Linda J. Noble1, Frances Donovan2, Takuji Igarashi1, Staci Goussev1, and Zena Werb2 Departments of 1 Neurosurgery and 2 Anatomy, University of California at San Francisco, San Francisco, California 94143-0520
Inflammation in general and proteinases generated as a result are likely mediators of early secondary pathogenesis after spinal cord injury. We report that matrix metalloproteinase-9 (MMP-9) plays an important role in blood-spinal cord barrier dysfunction, inflammation, and locomotor recovery. MMP-9 was present in the meninges and neurons of the uninjured cord. MMP-9 increased rapidly after a moderate contusion spinal cord injury, reaching a maximum at 24 hr, becoming markedly reduced by 72 hr, and not detectable at 7 d after injury. It was seen in glia, macrophages, neutrophils, and vascular elements in the injured spinal cord at 24 hr after injury. The natural tissue inhibitors of MMPs were unchanged over this time course. MMP-9-null mice exhibited significantly less disruption of the blood-spinal cord barrier, attenuation of neutrophil infiltration, and significant locomotor recovery compared with wild-type mice. Similar findings were observed in mice treated with a hydroxamic acid MMP inhibitor from 3 hr to 3 d after injury, compared with the vehicle controls. Moreover, the area of residual white matter at the lesion epicenter was significantly greater in the inhibitor-treated group. This study provides evidence that MMP-9 plays a key role in abnormal vascular permeability and inflammation within the first 3 d after spinal cord injury, and that blockade of MMPs during this critical period attenuates these vascular events and leads to improved locomotor recovery. Our findings suggest that early inhibition of MMPs may be an efficacious strategy for the spinal cord-injured patient.
Key words: blood-spinal cord barrier; inflammation; locomotor recovery; matrix metalloproteinase-9; proteinases; spinal cord injury
Copyright © 2002 Society for Neuroscience 0270-6474/02/22177526-10$05.00/0
This article has been cited by other articles:
M. Hashimoto, D. Sun, S. R. Rittling, D. T. Denhardt, and W. Young
Osteopontin-Deficient Mice Exhibit Less Inflammation, Greater Tissue Damage, and Impaired Locomotor Recovery from Spinal Cord Injury Compared with Wild-Type Controls
J. Neurosci., March 28, 2007; 27(13): 3603 - 3611.
[Abstract] [Full Text] [PDF]
J. C. Fleming, M. D. Norenberg, D. A. Ramsay, G. A. Dekaban, A. E. Marcillo, A. D. Saenz, M. Pasquale-Styles, W. D. Dietrich, and L. C. Weaver
The cellular inflammatory response in human spinal cords after injury
Brain, December 1, 2006; 129(12): 3249 - 3269.
[Abstract] [Full Text] [PDF]
J.-Y. C. Hsu, R. McKeon, S. Goussev, Z. Werb, J.-U. Lee, A. Trivedi, and L. J. Noble-Haeusslein
Matrix Metalloproteinase-2 Facilitates Wound Healing Events That Promote Functional Recovery after Spinal Cord Injury
J. Neurosci., September 27, 2006; 26(39): 9841 - 9850.
[Abstract] [Full Text] [PDF]
F. Qiao, C. Atkinson, H. Song, R. Pannu, I. Singh, and S. Tomlinson
Complement Plays an Important Role in Spinal Cord Injury and Represents a Therapeutic Target for Improving Recovery following Trauma
Am. J. Pathol., September 1, 2006; 169(3): 1039 - 1047.
[Abstract] [Full Text] [PDF]
M. L. Lindsey, G. P. Escobar, L. W. Dobrucki, D. K. Goshorn, S. Bouges, J. T. Mingoia, D. M. McClister Jr., H. Su, J. Gannon, C. MacGillivray, et al.
Matrix metalloproteinase-9 gene deletion facilitates angiogenesis after myocardial infarction
Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H232 - H239.
[Abstract] [Full Text] [PDF]
A. Gorio, L. Madaschi, B. Di Stefano, S. Carelli, A. M. Di Giulio, S. De Biasi, T. Coleman, A. Cerami, and M. Brines
From The Cover: Methylprednisolone neutralizes the beneficial effects of erythropoietin in experimental spinal cord injury
PNAS, November 8, 2005; 102(45): 16379 - 16384.
[Abstract] [Full Text] [PDF]
E. D. Shwartz
MRI and the Evaluation of the Blood-Spinal Cord Barrier following Injury
AJNR Am. J. Neuroradiol., August 1, 2005; 26(7): 1609 - 1610.
[Full Text] [PDF]
T. M. Kauppinen and R. A. Swanson
Poly(ADP-Ribose) Polymerase-1 Promotes Microglial Activation, Proliferation, and Matrix Metalloproteinase-9-Mediated Neuron Death
J. Immunol., February 15, 2005; 174(4): 2288 - 2296.
[Abstract] [Full Text] [PDF]
M. J. Velardo, C. Burger, P. R. Williams, H. V. Baker, M. C. Lopez, T. H. Mareci, T. E. White, N. Muzyczka, and P. J. Reier
Patterns of Gene Expression Reveal a Temporally Orchestrated Wound Healing Response in the Injured Spinal Cord
J. Neurosci., September 29, 2004; 24(39): 8562 - 8576.
[Abstract] [Full Text] [PDF]
P. H. Larsen, J. E. Wells, W. B. Stallcup, G. Opdenakker, and V. W. Yong
Matrix Metalloproteinase-9 Facilitates Remyelination in Part by Processing the Inhibitory NG2 Proteoglycan
J. Neurosci., December 3, 2003; 23(35): 11127 - 11135.
[Abstract] [Full Text] [PDF]
J. E. A. Wells, T. K. Rice, R. K. Nuttall, D. R. Edwards, H. Zekki, S. Rivest, and V. W. Yong
An Adverse Role for Matrix Metalloproteinase 12 after Spinal Cord Injury in Mice
J. Neurosci., November 5, 2003; 23(31): 10107 - 10115.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|